A 0 1 0 1 O
cluster 2 9 2 9 O
of 10 12 10 12 O
differentiation 13 28 13 28 O
( 29 30 29 30 O
CD)4 30 34 30 34 O
+ 34 35 34 35 O
lymphocyte 36 46 36 46 B-clinical_variable
count 47 52 47 52 I-clinical_variable
> 53 54 53 54 O
50 55 57 55 57 B-lower_bound
/ 57 58 57 58 I-lower_bound
mcL 58 61 58 61 I-lower_bound
will 62 66 62 66 O
be 67 69 67 69 O
required 70 78 70 78 O
within 79 85 79 85 O
2 86 87 86 87 B-upper_bound
weeks 88 93 88 93 I-upper_bound
of 94 96 94 96 O
study 97 102 97 102 O
participation 103 116 103 116 O

Absolute 0 8 117 125 B-clinical_variable
neutrophil 9 19 126 136 I-clinical_variable
count 20 25 137 142 I-clinical_variable
> 26 27 143 144 O
= 27 28 144 145 O
1,500 29 34 146 151 B-lower_bound
/ 34 35 151 152 I-lower_bound
mcL 35 38 152 155 I-lower_bound
( 39 40 156 157 O
within 40 46 157 163 O
1 47 48 164 165 B-upper_bound
week 49 53 166 170 I-upper_bound
of 54 56 171 173 O
study 57 62 174 179 O
entry 63 68 180 185 O
) 68 69 185 186 O

Active 0 6 187 193 B-chronic_disease
infection 7 16 194 203 I-chronic_disease
requiring 17 26 204 213 O
systemic 27 35 214 222 B-treatment
treatment 36 45 223 232 I-treatment
within 46 52 233 239 O
28 53 55 240 242 B-upper_bound
days 56 60 243 247 I-upper_bound
before 61 67 248 254 O
the 68 71 255 258 O
first 72 77 259 264 O
dose 78 82 265 269 O
of 83 85 270 272 O
study 86 91 273 278 O
treatment 92 101 279 288 O

Active 0 6 289 295 B-chronic_disease
peptic 7 13 296 302 I-chronic_disease
ulcer 14 19 303 308 I-chronic_disease
disease 20 27 309 316 I-chronic_disease

Antibiotics 0 11 317 328 B-treatment
: 11 12 328 329 O
clarithromycin 13 27 330 344 B-treatment
, 27 28 344 345 O
erythromycin 29 41 346 358 B-treatment
, 41 42 358 359 O
telithromycin 43 56 360 373 B-treatment
, 56 57 373 374 O
troleandomycin 58 72 375 389 B-treatment

Antidepressants 0 15 390 405 B-treatment
: 15 16 405 406 O
nefazodone 17 27 407 417 B-treatment

Antidiuretic 0 12 418 430 B-treatment
: 12 13 430 431 O
conivaptan 14 24 432 442 B-treatment

Antifungals 0 11 443 454 B-treatment
: 11 12 454 455 O
itraconazole 13 25 456 468 B-treatment
, 25 26 468 469 O
ketoconazole 27 39 470 482 B-treatment
, 39 40 482 483 O
voriconazole 41 53 484 496 B-treatment
, 53 54 496 497 O
fluconazole 55 66 498 509 B-treatment
, 66 67 509 510 O
posaconazole 68 80 511 523 B-treatment

Any 0 3 524 527 O
history 4 11 528 535 O
of 12 14 536 538 O
congenital 15 25 539 549 B-chronic_disease
long 26 30 550 554 I-chronic_disease
QT 31 33 555 557 I-chronic_disease
syndrome 34 42 558 566 I-chronic_disease

Any 0 3 567 570 O
of 4 6 571 573 O
the 7 10 574 577 O
following 11 20 578 587 O
within 21 27 588 594 O
28 28 30 595 597 B-upper_bound
days 31 35 598 602 I-upper_bound
before 36 42 603 609 O
the 43 46 610 613 O
first 47 52 614 619 O
dose 53 57 620 624 O
of 58 60 625 627 O
study 61 66 628 633 O
treatment 67 76 634 643 B-treatment

Any 0 3 644 647 O
of 4 6 648 650 O
the 7 10 651 654 O
following 11 20 655 664 O
within 21 27 665 671 O
6 28 29 672 673 B-upper_bound
months 30 36 674 680 I-upper_bound
before 37 43 681 687 O
the 44 47 688 691 O
first 48 53 692 697 O
dose 54 58 698 702 O
of 59 61 703 705 O
study 62 67 706 711 B-treatment
treatment 68 77 712 721 I-treatment

Any 0 3 722 725 O
other 4 9 726 731 O
signs 10 15 732 737 O
indicative 16 26 738 748 O
of 27 29 749 751 O
pulmonary 30 39 752 761 B-chronic_disease
hemorrhage 40 50 762 772 I-chronic_disease
within 51 57 773 779 O
3 58 59 780 781 B-upper_bound
months 60 66 782 788 I-upper_bound
before 67 73 789 795 I-upper_bound
the 74 77 796 799 O
first 78 83 800 805 O
dose 84 88 806 810 O
of 89 91 811 813 O
study 92 97 814 819 O
treatment 98 107 820 829 B-treatment

Aspartate 0 9 830 839 B-clinical_variable
aminotransferase 10 26 840 856 I-clinical_variable
( 27 28 857 858 I-clinical_variable
AST 28 31 858 861 I-clinical_variable
) 31 32 861 862 I-clinical_variable
( 33 34 863 864 O
serum 34 39 864 869 B-clinical_variable
glutamic 40 48 870 878 I-clinical_variable
oxaloacetic 49 60 879 890 I-clinical_variable
transaminase 61 73 891 903 I-clinical_variable
[ 74 75 904 905 I-clinical_variable
SGOT])/alanine 75 89 905 919 I-clinical_variable
aminotransferase 90 106 920 936 I-clinical_variable
( 107 108 937 938 I-clinical_variable
ALT 108 111 938 941 I-clinical_variable
) 111 112 941 942 I-clinical_variable
( 113 114 943 944 O
serum 114 119 944 949 B-clinical_variable
glutamate 120 129 950 959 I-clinical_variable
pyruvate 130 138 960 968 I-clinical_variable
transaminase 139 151 969 981 I-clinical_variable
[ 152 153 982 983 I-clinical_variable
SGPT 153 157 983 987 I-clinical_variable
] 157 158 987 988 I-clinical_variable
) 158 159 988 989 O
= 160 161 990 991 O
< 161 162 991 992 O
3.0 163 166 993 996 B-upper_bound
x 167 168 997 998 I-upper_bound
institutional 169 182 999 1012 I-upper_bound
upper 183 188 1013 1018 I-upper_bound
limit 189 194 1019 1024 I-upper_bound
of 195 197 1025 1027 I-upper_bound
normal 198 204 1028 1034 I-upper_bound
( 205 206 1035 1036 O
within 206 212 1036 1042 O
1 213 214 1043 1044 B-upper_bound
week 215 219 1045 1049 I-upper_bound
of 220 222 1050 1052 O
study 223 228 1053 1058 O
entry 229 234 1059 1064 O
) 234 235 1064 1065 O

Bowel 0 5 1066 1071 B-chronic_disease
obstruction 6 17 1072 1083 I-chronic_disease
or 18 20 1084 1086 O
gastric 21 28 1087 1094 B-chronic_disease
outlet 29 35 1095 1101 I-chronic_disease
obstruction 36 47 1102 1113 I-chronic_disease

Calcium 0 7 1114 1121 B-clinical_variable
> 8 9 1122 1123 O
= 9 10 1123 1124 O
LLN 11 14 1125 1128 O
( 15 16 1129 1130 O
within 16 22 1130 1136 O
1 23 24 1137 1138 B-upper_bound
week 25 29 1139 1143 I-upper_bound
of 30 32 1144 1146 O
study 33 38 1147 1152 O
entry 39 44 1153 1158 O
) 44 45 1158 1159 O

Cardiovascular 0 14 1160 1174 B-chronic_disease
disorders 15 24 1175 1184 I-chronic_disease

Clinically 0 10 1185 1195 O
- 10 11 1195 1196 O
significant 11 22 1196 1207 O
cardiac 23 30 1208 1215 B-chronic_disease
arrhythmias 31 42 1216 1227 I-chronic_disease

Clinically 0 10 1228 1238 O
- 10 11 1238 1239 O
significant 11 22 1239 1250 O
gastrointestinal 23 39 1251 1267 B-chronic_disease
bleeding 40 48 1268 1276 I-chronic_disease
within 49 55 1277 1283 O
6 56 57 1284 1285 B-upper_bound
months 58 64 1286 1292 I-upper_bound
before 65 71 1293 1299 I-upper_bound
the 72 75 1300 1303 O
first 76 81 1304 1309 O
dose 82 86 1310 1314 O
of 87 89 1315 1317 O
study 90 95 1318 1323 O
treatment 96 105 1324 1333 B-treatment

Concurrent 0 10 1334 1344 O
uncompensated 11 24 1345 1358 O
hypothyroidism 25 39 1359 1373 B-chronic_disease
or 40 42 1374 1376 O
thyroid 43 50 1377 1384 B-chronic_disease
dysfunction 51 62 1385 1396 I-chronic_disease
within 63 69 1397 1403 O
7 70 71 1404 1405 B-upper_bound
days 72 76 1406 1410 I-upper_bound
before 77 83 1411 1417 I-upper_bound
the 84 87 1418 1421 O
first 88 93 1422 1427 O
dose 94 98 1428 1432 O
of 99 101 1433 1435 O
study 102 107 1436 1441 O
treatment 108 117 1442 1451 B-treatment

Concurrent 0 10 1452 1462 O
uncontrolled 11 23 1463 1475 O
hypertension 24 36 1476 1488 B-chronic_disease
defined 37 44 1489 1496 O
as 45 47 1497 1499 O
sustained 48 57 1500 1509 O
blood 58 63 1510 1515 B-clinical_variable
pressure 64 72 1516 1524 I-clinical_variable
( 73 74 1525 1526 I-clinical_variable
BP 74 76 1526 1528 I-clinical_variable
) 76 77 1528 1529 I-clinical_variable
> 78 79 1530 1531 O
140 80 83 1532 1535 B-lower_bound
mmHg 84 88 1536 1540 I-lower_bound
systolic 89 97 1541 1549 B-clinical_variable
, 97 98 1549 1550 O
or 99 101 1551 1553 O
> 102 103 1554 1555 O
90 104 106 1556 1558 B-lower_bound
mmHg 107 111 1559 1563 I-lower_bound
diastolic 112 121 1564 1573 O
despite 122 129 1574 1581 O
optimal 130 137 1582 1589 B-treatment
antihypertensive 138 154 1590 1606 I-treatment
treatment 155 164 1607 1616 I-treatment
within 165 171 1617 1623 O
7 172 173 1624 1625 B-upper_bound
days 174 178 1626 1630 I-upper_bound
of 179 181 1631 1633 O
the 182 185 1634 1637 O
first 186 191 1638 1643 O
dose 192 196 1644 1648 O
of 197 199 1649 1651 O
study 200 205 1652 1657 O
treatment 206 215 1658 1667 O

Congestive 0 10 1668 1678 B-chronic_disease
heart 11 16 1679 1684 I-chronic_disease
failure 17 24 1685 1692 I-chronic_disease
( 25 26 1693 1694 I-chronic_disease
CHF 26 29 1694 1697 I-chronic_disease
): 29 31 1697 1699 I-chronic_disease
New 32 35 1700 1703 B-clinical_variable
York 36 40 1704 1708 I-clinical_variable
Heart 41 46 1709 1714 I-clinical_variable
Association 47 58 1715 1726 I-clinical_variable
( 59 60 1727 1728 I-clinical_variable
NYHA 60 64 1728 1732 I-clinical_variable
) 64 65 1732 1733 I-clinical_variable
class 66 71 1734 1739 B-lower_bound
III 72 75 1740 1743 I-lower_bound
( 76 77 1744 1745 I-lower_bound
moderate 77 85 1745 1753 I-lower_bound
) 85 86 1753 1754 I-lower_bound
or 87 89 1755 1757 O
class 90 95 1758 1763 B-upper_bound
IV 96 98 1764 1766 I-upper_bound
( 99 100 1767 1768 I-upper_bound
severe 100 106 1768 1774 I-upper_bound
) 106 107 1774 1775 I-upper_bound
at 108 110 1776 1778 O
the 111 114 1779 1782 O
time 115 119 1783 1787 O
of 120 122 1788 1790 O
screening 123 132 1791 1800 O

Creatinine 0 10 1801 1811 B-clinical_variable
= 11 12 1812 1813 O
< 12 13 1813 1814 O
1.5 14 17 1815 1818 B-upper_bound
x 18 19 1819 1820 I-upper_bound
ULN 20 23 1821 1824 I-upper_bound
( 24 25 1825 1826 O
within 25 31 1826 1832 O
1 32 33 1833 1834 B-upper_bound
week 34 38 1835 1839 I-upper_bound
of 39 41 1840 1842 O
study 42 47 1843 1848 O
entry 48 53 1849 1854 O
) 53 54 1854 1855 O

Creatinine 0 10 1856 1866 B-clinical_variable
clearance 11 20 1867 1876 I-clinical_variable
> 21 22 1877 1878 O
= 22 23 1878 1879 O
50 24 26 1880 1882 B-lower_bound
mL 27 29 1883 1885 I-lower_bound
/ 29 30 1885 1886 I-lower_bound
min/1.73 30 38 1886 1894 I-lower_bound
m^2 39 42 1895 1898 I-lower_bound
for 43 46 1899 1902 O
participants 47 59 1903 1915 O
with 60 64 1916 1920 O
creatinine 65 75 1921 1931 B-clinical_variable
levels 76 82 1932 1938 O
above 83 88 1939 1944 O
institutional 89 102 1945 1958 O
normal 103 109 1959 1965 O
( 110 111 1966 1967 O
within 111 117 1967 1973 O
1 118 119 1974 1975 B-upper_bound
week 120 124 1976 1980 I-upper_bound
of 125 127 1981 1983 O
study 128 133 1984 1989 O
entry 134 139 1990 1995 O
) 139 140 1995 1996 O

Eastern 0 7 1997 2004 B-clinical_variable
Cooperative 8 19 2005 2016 I-clinical_variable
Oncology 20 28 2017 2025 I-clinical_variable
Group 29 34 2026 2031 I-clinical_variable
( 35 36 2032 2033 I-clinical_variable
ECOG 36 40 2033 2037 I-clinical_variable
) 40 41 2037 2038 I-clinical_variable
performance 42 53 2039 2050 I-clinical_variable
status 54 60 2051 2057 I-clinical_variable
= 61 62 2058 2059 O
< 62 63 2059 2060 O
2 64 65 2061 2062 B-upper_bound
( 66 67 2063 2064 O
Karnofsky 67 76 2064 2073 B-clinical_variable
> 77 78 2074 2075 O
= 78 79 2075 2076 O
60 80 82 2077 2079 B-lower_bound
% 82 83 2079 2080 I-lower_bound
) 83 84 2080 2081 O

Gastrointestinal 0 16 2082 2098 B-chronic_disease
( 17 18 2099 2100 I-chronic_disease
GI 18 20 2100 2102 I-chronic_disease
): 20 22 2102 2104 I-chronic_disease
cimetidine 23 33 2105 2115 B-treatment
, 33 34 2115 2116 O
aprepitant 35 45 2117 2127 B-treatment

Gastrointestinal 0 16 2128 2144 B-chronic_disease
disorders 17 26 2145 2154 I-chronic_disease
particularly 27 39 2155 2167 O
those 40 45 2168 2173 O
associated 46 56 2174 2184 O
with 57 61 2185 2189 O
a 62 63 2190 2191 O
high 64 68 2192 2196 O
risk 69 73 2197 2201 O
of 74 76 2202 2204 O
perforation 77 88 2205 2216 O
or 89 91 2217 2219 O
fistula 92 99 2220 2227 O
formation 100 109 2228 2237 O

Gastrointestinal 0 16 2238 2254 B-chronic_disease
perforation 17 28 2255 2266 I-chronic_disease

Hemoglobin 0 10 2267 2277 B-clinical_variable
> 11 12 2278 2279 O
= 12 13 2279 2280 O
9 14 15 2281 2282 B-lower_bound
g 16 17 2283 2284 I-lower_bound
/ 17 18 2284 2285 I-lower_bound
dL 18 20 2285 2287 I-lower_bound
( 21 22 2288 2289 O
within 22 28 2289 2295 O
1 29 30 2296 2297 B-upper_bound
week 31 35 2298 2302 I-upper_bound
of 36 38 2303 2305 O
study 39 44 2306 2311 O
entry 45 50 2312 2317 O
) 50 51 2317 2318 O

Hemoptysis 0 10 2319 2329 B-clinical_variable
of 11 13 2330 2332 O
> 14 15 2333 2334 O
= 15 16 2334 2335 O
0.5 17 20 2336 2339 B-lower_bound
teaspoon 21 29 2340 2348 I-lower_bound
( 30 31 2349 2350 I-lower_bound
2.5 31 34 2350 2353 I-lower_bound
mL 35 37 2354 2356 I-lower_bound
) 37 38 2356 2357 I-lower_bound
of 39 41 2358 2360 O
red 42 45 2361 2364 O
blood 46 51 2365 2370 O
within 52 58 2371 2377 O
3 59 60 2378 2379 B-upper_bound
months 61 67 2380 2386 I-upper_bound
before 68 74 2387 2393 O
the 75 78 2394 2397 O
first 79 84 2398 2403 O
dose 85 89 2404 2408 O
of 90 92 2409 2411 O
study 93 98 2412 2417 O
treatment 99 108 2418 2427 B-treatment

Hepatitis 0 9 2428 2437 B-chronic_disease
C 10 11 2438 2439 I-chronic_disease
: 11 12 2439 2440 O
boceprevir 13 23 2441 2451 B-treatment
, 23 24 2451 2452 O
telaprevir 25 35 2453 2463 B-treatment

History 0 7 2464 2471 O
of 8 10 2472 2474 O
major 11 16 2475 2480 O
surgery 17 24 2481 2488 B-treatment

History 0 7 2489 2496 O
of 8 10 2497 2499 O
organ 11 16 2500 2505 B-treatment
transplant 17 27 2506 2516 I-treatment

Intra 0 5 2517 2522 B-chronic_disease
- 5 6 2522 2523 I-chronic_disease
abdominal 6 15 2523 2532 I-chronic_disease
abscess 16 23 2533 2540 I-chronic_disease
; 23 24 2540 2541 O
note 25 29 2542 2546 O
: 29 30 2546 2547 O
complete 31 39 2548 2556 O
resolution 40 50 2557 2567 O
of 51 53 2568 2570 O
an 54 56 2571 2573 O
intra 57 62 2574 2579 B-chronic_disease
- 62 63 2579 2580 I-chronic_disease
abdominal 63 72 2580 2589 I-chronic_disease
abscess 73 80 2590 2597 I-chronic_disease
must 81 85 2598 2602 O
be 86 88 2603 2605 O
confirmed 89 98 2606 2615 O
prior 99 104 2616 2621 O
to 105 107 2622 2624 O
initiating 108 118 2625 2635 O
treatment 119 128 2636 2645 B-treatment
with 129 133 2646 2650 I-treatment
cabozantinib 134 146 2651 2663 I-treatment
even 147 151 2664 2668 O
if 152 154 2669 2671 O
the 155 158 2672 2675 O
abscess 159 166 2676 2683 O
occurred 167 175 2684 2692 O
more 176 180 2693 2697 O
than 181 185 2698 2702 O
6 186 187 2703 2704 B-lower_bound
months 188 194 2705 2711 I-lower_bound
before 195 201 2712 2718 I-lower_bound
the 202 205 2719 2722 O
first 206 211 2723 2728 O
dose 212 216 2729 2733 O
of 217 219 2734 2736 O
study 220 225 2737 2742 O
treatment 226 235 2743 2752 O

Leukocytes 0 10 2753 2763 B-clinical_variable
> 11 12 2764 2765 O
= 12 13 2765 2766 O
3,000 14 19 2767 2772 B-lower_bound
/ 19 20 2772 2773 I-lower_bound
mcL 20 23 2773 2776 I-lower_bound
( 24 25 2777 2778 O
within 25 31 2778 2784 O
1 32 33 2785 2786 B-upper_bound
week 34 38 2787 2791 I-upper_bound
of 39 41 2792 2794 O
study 42 47 2795 2800 O
entry 48 53 2801 2806 O
) 53 54 2806 2807 O

Life 0 4 2808 2812 B-clinical_variable
expectancy 5 15 2813 2823 I-clinical_variable
of 16 18 2824 2826 O
greater 19 26 2827 2834 O
than 27 31 2835 2839 O
12 32 34 2840 2842 B-lower_bound
weeks 35 40 2843 2848 I-lower_bound

Lipase 0 6 2849 2855 B-clinical_variable
< 7 8 2856 2857 O
2.0 9 12 2858 2861 B-upper_bound
x 13 14 2862 2863 I-upper_bound
ULN 15 18 2864 2867 I-upper_bound
and 19 22 2868 2871 O
no 23 25 2872 2874 O
radiologic 26 36 2875 2885 O
or 37 39 2886 2888 O
clinical 40 48 2889 2897 O
evidence 49 57 2898 2906 O
of 58 60 2907 2909 O
pancreatitis 61 73 2910 2922 B-chronic_disease
( 74 75 2923 2924 O
within 75 81 2924 2930 O
1 82 83 2931 2932 B-upper_bound
week 84 88 2933 2937 I-upper_bound
of 89 91 2938 2940 O
study 92 97 2941 2946 O
entry 98 103 2947 2952 O
) 103 104 2952 2953 O

Magnesium 0 9 2954 2963 B-clinical_variable
> 10 11 2964 2965 O
= 11 12 2965 2966 O
LLN 13 16 2967 2970 B-clinical_variable
( 17 18 2971 2972 O
within 18 24 2972 2978 O
1 25 26 2979 2980 B-upper_bound
week 27 31 2981 2985 I-upper_bound
of 32 34 2986 2988 O
study 35 40 2989 2994 O
entry 41 46 2995 3000 O
) 46 47 3000 3001 O

Major 0 5 3002 3007 B-treatment
surgery 6 13 3008 3015 I-treatment
within 14 20 3016 3022 O
3 21 22 3023 3024 B-upper_bound
months 23 29 3025 3031 I-upper_bound
of 30 32 3032 3034 O
the 33 36 3035 3038 O
first 37 42 3039 3044 O
dose 43 47 3045 3049 O
of 48 50 3050 3052 O
cabozantinib 51 63 3053 3065 B-treatment
if 64 66 3066 3068 O
there 67 72 3069 3074 O
were 73 77 3075 3079 O
no 78 80 3080 3082 O
wound 81 86 3083 3088 O
healing 87 94 3089 3096 O
complications 95 108 3097 3110 O
or 109 111 3111 3113 O
within 112 118 3114 3120 O
6 119 120 3121 3122 B-upper_bound
months 121 127 3123 3129 I-upper_bound
of 128 130 3130 3132 O
the 131 134 3133 3136 O
first 135 140 3137 3142 O
dose 141 145 3143 3147 O
of 146 148 3148 3150 O
cabozantinib 149 161 3151 3163 O
if 162 164 3164 3166 O
there 165 170 3167 3172 O
were 171 175 3173 3177 O
wound 176 181 3178 3183 O
complications 182 195 3184 3197 O

Minor 0 5 3198 3203 B-treatment
surgery 6 13 3204 3211 I-treatment
within 14 20 3212 3218 O
1 21 22 3219 3220 B-upper_bound
month 23 28 3221 3226 I-upper_bound
of 29 31 3227 3229 O
the 32 35 3230 3233 O
first 36 41 3234 3239 O
dose 42 46 3240 3244 O
of 47 49 3245 3247 O
cabozantinib 50 62 3248 3260 B-treatment
if 63 65 3261 3263 O
there 66 71 3264 3269 O
were 72 76 3270 3274 O
no 77 79 3275 3277 O
wound 80 85 3278 3283 O
healing 86 93 3284 3291 O
complications 94 107 3292 3305 O
or 108 110 3306 3308 O
within 111 117 3309 3315 O
3 118 119 3316 3317 B-upper_bound
months 120 126 3318 3324 I-upper_bound
of 127 129 3325 3327 O
the 130 133 3328 3331 O
first 134 139 3332 3337 O
dose 140 144 3338 3342 O
of 145 147 3343 3345 O
cabozantinib 148 160 3346 3358 O
if 161 163 3359 3361 O
there 164 169 3362 3367 O
were 170 174 3368 3372 O
wound 175 180 3373 3378 O
complications 181 194 3379 3392 O

Myocardial 0 10 3393 3403 B-chronic_disease
infarction 11 21 3404 3414 I-chronic_disease

Other 0 5 3415 3420 O
disorders 6 15 3421 3430 O
associated 16 26 3431 3441 O
with 27 31 3442 3446 O
a 32 33 3447 3448 O
high 34 38 3449 3453 O
risk 39 43 3454 3458 O
of 44 46 3459 3461 O
fistula 47 54 3462 3469 O
formation 55 64 3470 3479 O
including 65 74 3480 3489 O
percutaneous 75 87 3490 3502 B-treatment
endoscopic 88 98 3503 3513 I-treatment
gastrostomy 99 110 3514 3525 I-treatment
( 111 112 3526 3527 I-treatment
PEG 112 115 3527 3530 I-treatment
) 115 116 3530 3531 I-treatment
tube 117 121 3532 3536 I-treatment
placement 122 131 3537 3546 I-treatment
within 132 138 3547 3553 O
3 139 140 3554 3555 B-upper_bound
months 141 147 3556 3562 I-upper_bound
before 148 154 3563 3569 I-upper_bound
the 155 158 3570 3573 O
first 159 164 3574 3579 O
dose 165 169 3580 3584 O
of 170 172 3585 3587 O
study 173 178 3588 3593 B-treatment
therapy 179 186 3594 3601 I-treatment

Participants 0 12 3602 3614 O
must 13 17 3615 3619 O
have 18 22 3620 3624 O
known 23 28 3625 3630 O
HIV 29 32 3631 3634 B-chronic_disease
infection 33 42 3635 3644 O
and 43 46 3645 3648 O
histologically 47 61 3649 3663 O
confirmed 62 71 3664 3673 O
solid 72 77 3674 3679 B-cancer
malignancy 78 88 3680 3690 I-cancer
that 89 93 3691 3695 O
is 94 96 3696 3698 O
metastatic 97 107 3699 3709 O
or 108 110 3710 3712 O
unresectable 111 123 3713 3725 O
and 124 127 3726 3729 O
for 128 131 3730 3733 O
which 132 137 3734 3739 O
standard 138 146 3740 3748 O
curative 147 155 3749 3757 O
or 156 158 3758 3760 O
palliative 159 169 3761 3771 O
measures 170 178 3772 3780 O
do 179 181 3781 3783 O
not 182 185 3784 3787 O
exist 186 191 3788 3793 O
or 192 194 3794 3796 O
are 195 198 3797 3800 O
no 199 201 3801 3803 O
longer 202 208 3804 3810 O
effective 209 218 3811 3820 O

Participating 0 13 3821 3834 O
participants 14 26 3835 3847 O
MUST 27 31 3848 3852 O
receive 32 39 3853 3860 O
appropriate 40 51 3861 3872 O
care 52 56 3873 3877 O
and 57 60 3878 3881 O
treatment 61 70 3882 3891 B-treatment
for 71 74 3892 3895 O
HIV 75 78 3896 3899 B-treatment
infection 79 88 3900 3909 I-chronic_disease
, 88 89 3909 3910 O
including 90 99 3911 3920 O
antiretroviral 100 114 3921 3935 B-treatment
medications 115 126 3936 3947 I-treatment
, 126 127 3947 3948 O
when 128 132 3949 3953 O
clinically 133 143 3954 3964 O
indicated 144 153 3965 3974 O
and 154 157 3975 3978 O
should 158 164 3979 3985 O
be 165 167 3986 3988 O
under 168 173 3989 3994 O
the 174 177 3995 3998 O
care 178 182 3999 4003 O
of 183 185 4004 4006 O
a 186 187 4007 4008 O
physician 188 197 4009 4018 O
experienced 198 209 4019 4030 O
in 210 212 4031 4033 O
HIV 213 216 4034 4037 O
management 217 227 4038 4048 O

Platelets 0 9 4049 4058 B-clinical_variable
> 10 11 4059 4060 O
= 11 12 4060 4061 O
100,000 13 20 4062 4069 B-lower_bound
/ 20 21 4069 4070 I-lower_bound
mcL 21 24 4070 4073 I-lower_bound
( 25 26 4074 4075 O
within 26 32 4075 4081 O
1 33 34 4082 4083 B-upper_bound
week 35 39 4084 4088 I-upper_bound
of 40 42 4089 4091 O
study 43 48 4092 4097 O
entry 49 54 4098 4103 O
) 54 55 4103 4104 O

Potassium 0 9 4105 4114 B-clinical_variable
> 10 11 4115 4116 O
= 11 12 4116 4117 O
LLN 13 16 4118 4121 O
( 17 18 4122 4123 O
within 18 24 4123 4129 O
1 25 26 4130 4131 B-upper_bound
week 27 31 4132 4136 I-upper_bound
of 32 34 4137 4139 O
study 35 40 4140 4145 O
entry 41 46 4146 4151 O
) 46 47 4151 4152 O

Prior 0 5 4153 4158 B-treatment
treatment 6 15 4159 4168 I-treatment
with 16 20 4169 4173 I-treatment
cabozantinib 21 33 4174 4186 I-treatment
( 34 35 4187 4188 I-treatment
XL184 35 40 4188 4193 I-treatment
) 40 41 4193 4194 I-treatment

Serious 0 7 4195 4202 O
non 8 11 4203 4206 O
- 11 12 4206 4207 O
healing 12 19 4207 4214 O
wound 20 25 4215 4220 O
/ 25 26 4220 4221 O
ulcer 26 31 4221 4226 B-chronic_disease
/ 31 32 4226 4227 O
bone 32 36 4227 4231 O
fracture 37 45 4232 4240 O
within 46 52 4241 4247 O
28 53 55 4248 4250 B-upper_bound
days 56 60 4251 4255 I-upper_bound
before 61 67 4256 4262 I-upper_bound
the 68 71 4263 4266 O
first 72 77 4267 4272 O
dose 78 82 4273 4277 O
of 83 85 4278 4280 O
study 86 91 4281 4286 O
treatment 92 101 4287 4296 B-treatment

Serologic 0 9 4297 4306 O
documentation 10 23 4307 4320 O
of 24 26 4321 4323 O
HIV 27 30 4324 4327 B-chronic_disease
infection 31 40 4328 4337 I-chronic_disease
at 41 43 4338 4340 O
any 44 47 4341 4344 O
time 48 52 4345 4349 O
prior 53 58 4350 4355 O
to 59 61 4356 4358 O
study 62 67 4359 4364 O
entry 68 73 4365 4370 O
, 73 74 4370 4371 O
as 75 77 4372 4374 O
evidenced 78 87 4375 4384 O
by 88 90 4385 4387 O
positive 91 99 4388 4396 O
enzyme 100 106 4397 4403 B-treatment
- 106 107 4403 4404 I-treatment
linked 107 113 4404 4410 I-treatment
immunosorbent 114 127 4411 4424 I-treatment
assay 128 133 4425 4430 I-treatment
( 134 135 4431 4432 I-treatment
ELISA 135 140 4432 4437 I-treatment
) 140 141 4437 4438 I-treatment
, 141 142 4438 4439 O
positive 143 151 4440 4448 B-treatment
western 152 159 4449 4456 I-treatment
blot 160 164 4457 4461 I-treatment
, 164 165 4461 4462 O
or 166 168 4463 4465 O
any 169 172 4466 4469 O
other 173 178 4470 4475 O
federally 179 188 4476 4485 O
approved 189 197 4486 4494 O
licensed 198 206 4495 4503 O
HIV 207 210 4504 4507 O
test 211 215 4508 4512 O
; 215 216 4512 4513 O
alternatively 217 230 4514 4527 O
, 230 231 4527 4528 O
this 232 236 4529 4533 O
documentation 237 250 4534 4547 O
may 251 254 4548 4551 O
include 255 262 4552 4559 O
a 263 264 4560 4561 O
record 265 271 4562 4568 O
that 272 276 4569 4573 O
another 277 284 4574 4581 O
physician 285 294 4582 4591 O
has 295 298 4592 4595 O
documented 299 309 4596 4606 O
that 310 314 4607 4611 O
the 315 318 4612 4615 O
participant 319 330 4616 4627 O
has 331 334 4628 4631 O
HIV 335 338 4632 4635 O
infection 339 348 4636 4645 O
based 349 354 4646 4651 O
on 355 357 4652 4654 O
prior 358 363 4655 4660 B-treatment
ELISA 364 369 4661 4666 I-treatment
and 370 373 4667 4670 I-treatment
western 374 381 4671 4678 I-treatment
blot 382 386 4679 4683 I-treatment
, 386 387 4683 4684 O
or 388 390 4685 4687 O
other 391 396 4688 4693 O
approved 397 405 4694 4702 O
diagnostic 406 416 4703 4713 O
tests 417 422 4714 4719 O

Serum 0 5 4720 4725 B-clinical_variable
albumin 6 13 4726 4733 I-clinical_variable
> 14 15 4734 4735 O
= 15 16 4735 4736 O
2.8 17 20 4737 4740 B-lower_bound
g 21 22 4741 4742 I-lower_bound
/ 22 23 4742 4743 I-lower_bound
dL 23 25 4743 4745 I-lower_bound
( 26 27 4746 4747 O
within 27 33 4747 4753 O
1 34 35 4754 4755 B-upper_bound
week 36 40 4756 4760 I-upper_bound
of 41 43 4761 4763 O
study 44 49 4764 4769 O
entry 50 55 4770 4775 O
) 55 56 4775 4776 O

Serum 0 5 4777 4782 B-clinical_variable
phosphorus 6 16 4783 4793 I-clinical_variable
> 17 18 4794 4795 O
= 18 19 4795 4796 O
lower 20 25 4797 4802 B-clinical_variable
limit 26 31 4803 4808 I-clinical_variable
of 32 34 4809 4811 I-clinical_variable
normal 35 41 4812 4818 I-clinical_variable
( 42 43 4819 4820 I-clinical_variable
LLN 43 46 4820 4823 I-clinical_variable
) 46 47 4823 4824 I-clinical_variable
( 48 49 4825 4826 O
within 49 55 4826 4832 O
1 56 57 4833 4834 B-upper_bound
week 58 62 4835 4839 I-upper_bound
of 63 65 4840 4842 O
study 66 71 4843 4848 O
entry 72 77 4849 4854 O
) 77 78 4854 4855 O

Stroke 0 6 4856 4862 B-chronic_disease
( 7 8 4863 4864 O
including 8 17 4864 4873 O
transient 18 27 4874 4883 B-chronic_disease
ischemic 28 36 4884 4892 I-chronic_disease
attack 37 43 4893 4899 I-chronic_disease
[ 44 45 4900 4901 I-chronic_disease
TIA 45 48 4901 4904 I-chronic_disease
] 48 49 4904 4905 I-chronic_disease
, 49 50 4905 4906 O
or 51 53 4907 4909 O
other 54 59 4910 4915 O
ischemic 60 68 4916 4924 O
event 69 74 4925 4930 O
) 74 75 4930 4931 O

The 0 3 4932 4935 O
effects 4 11 4936 4943 O
of 12 14 4944 4946 O
cabozantinib 15 27 4947 4959 B-treatment
on 28 30 4960 4962 O
the 31 34 4963 4966 O
developing 35 45 4967 4977 O
human 46 51 4978 4983 O
fetus 52 57 4984 4989 O
are 58 61 4990 4993 O
unknown 62 69 4994 5001 O
; 69 70 5001 5002 O
for 71 74 5003 5006 O
this 75 79 5007 5011 O
reason 80 86 5012 5018 O
and 87 90 5019 5022 O
because 91 98 5023 5030 O
tyrosine 99 107 5031 5039 O
kinase 108 114 5040 5046 O
inhibitors 115 125 5047 5057 O
agents 126 132 5058 5064 O
as 133 135 5065 5067 O
well 136 140 5068 5072 O
as 141 143 5073 5075 O
other 144 149 5076 5081 O
therapeutic 150 161 5082 5093 B-treatment
agents 162 168 5094 5100 I-treatment
used 169 173 5101 5105 O
in 174 176 5106 5108 O
this 177 181 5109 5113 O
trial 182 187 5114 5119 O
are 188 191 5120 5123 O
known 192 197 5124 5129 O
to 198 200 5130 5132 O
be 201 203 5133 5135 O
teratogenic 204 215 5136 5147 B-treatment
, 215 216 5147 5148 O
women 217 222 5149 5154 B-gender
of 223 225 5155 5157 O
child 226 231 5158 5163 O
- 231 232 5163 5164 O
bearing 232 239 5164 5171 O
potential 240 249 5172 5181 O
and 250 253 5182 5185 O
men 254 257 5186 5189 O
must 258 262 5190 5194 O
agree 263 268 5195 5200 B-contraception_consent
to 269 271 5201 5203 I-contraception_consent
use 272 275 5204 5207 I-contraception_consent
adequate 276 284 5208 5216 I-contraception_consent
contraception 285 298 5217 5230 I-contraception_consent
prior 299 304 5231 5236 O
to 305 307 5237 5239 O
study 308 313 5240 5245 O
entry 314 319 5246 5251 O
and 320 323 5252 5255 O
for 324 327 5256 5259 O
the 328 331 5260 5263 O
duration 332 340 5264 5272 O
of 341 343 5273 5275 O
study 344 349 5276 5281 O
participation 350 363 5282 5295 O

The 0 3 5296 5299 O
participant 4 15 5300 5311 O
has 16 19 5312 5315 O
a 20 21 5316 5317 O
corrected 22 31 5318 5327 O
QT 32 34 5328 5330 O
interval 35 43 5331 5339 O
calculated 44 54 5340 5350 O
by 55 57 5351 5353 O
the 58 61 5354 5357 O
Fridericia 62 72 5358 5368 B-clinical_variable
formula 73 80 5369 5376 I-clinical_variable
( 81 82 5377 5378 I-clinical_variable
QTcF 82 86 5378 5382 I-clinical_variable
) 86 87 5382 5383 I-clinical_variable
> 88 89 5384 5385 O
500 90 93 5386 5389 B-lower_bound
ms 94 96 5390 5392 I-lower_bound
within 97 103 5393 5399 O
28 104 106 5400 5402 B-upper_bound
days 107 111 5403 5407 I-upper_bound
before 112 118 5408 5414 I-upper_bound
randomization 119 132 5415 5428 O

The 0 3 5429 5432 O
participant 4 15 5433 5444 O
has 16 19 5445 5448 O
a 20 21 5449 5450 O
primary 22 29 5451 5458 B-cancer
brain 30 35 5459 5464 I-cancer
tumor 36 41 5465 5470 I-cancer

The 0 3 5471 5474 O
participant 4 15 5475 5486 O
has 16 19 5487 5490 O
active 20 26 5491 5497 O
brain 27 32 5498 5503 B-cancer
metastases 33 43 5504 5514 I-cancer
or 44 46 5515 5517 O
epidural 47 55 5518 5526 B-chronic_disease
disease 56 63 5527 5534 I-chronic_disease

The 0 3 5535 5538 O
participant 4 15 5539 5550 O
has 16 19 5551 5554 O
not 20 23 5555 5558 O
recovered 24 33 5559 5568 O
to 34 36 5569 5571 O
baseline 37 45 5572 5580 O
or 46 48 5581 5583 O
Common 49 55 5584 5590 B-clinical_variable
Terminology 56 67 5591 5602 I-clinical_variable
Criteria 68 76 5603 5611 I-clinical_variable
for 77 80 5612 5615 I-clinical_variable
Adverse 81 88 5616 5623 I-clinical_variable
Events 89 95 5624 5630 I-clinical_variable
( 96 97 5631 5632 I-clinical_variable
CTCAE 97 102 5632 5637 I-clinical_variable
) 102 103 5637 5638 I-clinical_variable
= 104 105 5639 5640 O
< 105 106 5640 5641 O
grade 107 112 5642 5647 B-upper_bound
1 113 114 5648 5649 I-upper_bound
from 115 119 5650 5654 O
toxicity 120 128 5655 5663 O
due 129 132 5664 5667 O
to 133 135 5668 5670 O
all 136 139 5671 5674 O
prior 140 145 5675 5680 B-treatment
therapies 146 155 5681 5690 I-treatment

The 0 3 5691 5694 O
participant 4 15 5695 5706 O
has 16 19 5707 5710 O
prothrombin 20 31 5711 5722 B-clinical_variable
time 32 36 5723 5727 I-clinical_variable
( 37 38 5728 5729 I-clinical_variable
PT)/international 38 55 5729 5746 I-clinical_variable
normalized 56 66 5747 5757 I-clinical_variable
ratio 67 72 5758 5763 I-clinical_variable
( 73 74 5764 5765 I-clinical_variable
INR 74 77 5765 5768 I-clinical_variable
) 77 78 5768 5769 I-clinical_variable
or 79 81 5770 5772 O
partial 82 89 5773 5780 B-clinical_variable
thromboplastin 90 104 5781 5795 I-clinical_variable
time 105 109 5796 5800 I-clinical_variable
( 110 111 5801 5802 I-clinical_variable
PTT 111 114 5802 5805 I-clinical_variable
) 114 115 5805 5806 I-clinical_variable
test 116 120 5807 5811 O
> 121 122 5812 5813 O
= 122 123 5813 5814 O
1.3 124 127 5815 5818 B-lower_bound
x 128 129 5819 5820 I-lower_bound
the 130 133 5821 5824 I-lower_bound
laboratory 134 144 5825 5835 I-lower_bound
ULN 145 148 5836 5839 I-lower_bound
within 149 155 5840 5846 O
7 156 157 5847 5848 B-upper_bound
days 158 162 5849 5853 I-upper_bound
before 163 169 5854 5860 I-upper_bound
the 170 173 5861 5864 O
first 174 179 5865 5870 O
dose 180 184 5871 5875 O
of 185 187 5876 5878 O
study 188 193 5879 5884 O
treatment 194 203 5885 5894 B-treatment

The 0 3 5895 5898 O
participant 4 15 5899 5910 O
has 16 19 5911 5914 O
radiographic 20 32 5915 5927 O
evidence 33 41 5928 5936 O
of 42 44 5937 5939 O
cavitating 45 55 5940 5950 B-chronic_disease
pulmonary 56 65 5951 5960 I-chronic_disease
lesion(s 66 74 5961 5969 I-chronic_disease
) 74 75 5969 5970 I-chronic_disease

The 0 3 5971 5974 O
participant 4 15 5975 5986 O
has 16 19 5987 5990 O
received 20 28 5991 5999 O
any 29 32 6000 6003 O
other 33 38 6004 6009 O
type 39 43 6010 6014 O
of 44 46 6015 6017 O
investigational 47 62 6018 6033 B-treatment
agent 63 68 6034 6039 I-treatment
within 69 75 6040 6046 O
28 76 78 6047 6049 B-upper_bound
days 79 83 6050 6054 I-upper_bound
before 84 90 6055 6061 I-upper_bound
the 91 94 6062 6065 O
first 95 100 6066 6071 O
dose 101 105 6072 6076 O
of 106 108 6077 6079 O
study 109 114 6080 6085 O
treatment 115 124 6086 6095 B-treatment

The 0 3 6096 6099 O
participant 4 15 6100 6111 O
has 16 19 6112 6115 O
received 20 28 6116 6124 O
prior 29 34 6125 6130 B-treatment
treatment 35 44 6131 6140 I-treatment
with 45 49 6141 6145 O
a 50 51 6146 6147 O
small 52 57 6148 6153 B-treatment
molecule 58 66 6154 6162 I-treatment
kinase 67 73 6163 6169 I-treatment
inhibitor 74 83 6170 6179 I-treatment
or 84 86 6180 6182 O
a 87 88 6183 6184 O
hormonal 89 97 6185 6193 B-treatment
therapy 98 105 6194 6201 I-treatment
( 106 107 6202 6203 O
including 107 116 6203 6212 O
investigational 117 132 6213 6228 O
kinase 133 139 6229 6235 O
inhibitors 140 150 6236 6246 O
or 151 153 6247 6249 O
hormones 154 162 6250 6258 O
) 162 163 6258 6259 O
within 164 170 6260 6266 O
4 171 172 6267 6268 B-upper_bound
weeks 173 178 6269 6274 I-upper_bound
or 179 181 6275 6277 O
five 182 186 6278 6282 B-upper_bound
half 187 191 6283 6287 I-upper_bound
- 191 192 6287 6288 I-upper_bound
lives 192 197 6288 6293 I-upper_bound
of 198 200 6294 6296 O
the 201 204 6297 6300 O
compound 205 213 6301 6309 O
or 214 216 6310 6312 O
active 217 223 6313 6319 O
metabolites 224 235 6320 6331 O
, 235 236 6331 6332 O
whichever 237 246 6333 6342 O
is 247 249 6343 6345 O
longer 250 256 6346 6352 O
, 256 257 6352 6353 O
before 258 264 6354 6360 O
the 265 268 6361 6364 O
first 269 274 6365 6370 O
dose 275 279 6371 6375 O
of 280 282 6376 6378 O
study 283 288 6379 6384 B-treatment
treatment 289 298 6385 6394 I-treatment

The 0 3 6395 6398 O
participant 4 15 6399 6410 O
has 16 19 6411 6414 O
received 20 28 6415 6423 O
radionuclide 29 41 6424 6436 B-treatment
treatment 42 51 6437 6446 I-treatment
within 52 58 6447 6453 O
6 59 60 6454 6455 B-upper_bound
weeks 61 66 6456 6461 I-upper_bound
of 67 69 6462 6464 O
the 70 73 6465 6468 O
first 74 79 6469 6474 O
dose 80 84 6475 6479 O
of 85 87 6480 6482 O
study 88 93 6483 6488 B-treatment
treatment 94 103 6489 6498 I-treatment

The 0 3 6499 6502 O
participant 4 15 6503 6514 O
has 16 19 6515 6518 O
tumor 20 25 6519 6524 B-cancer
invading 26 34 6525 6533 O
or 35 37 6534 6536 O
encasing 38 46 6537 6545 O
any 47 50 6546 6549 O
major 51 56 6550 6555 O
blood 57 62 6556 6561 O
vessels 63 70 6562 6569 O

The 0 3 6570 6573 O
participant 4 15 6574 6585 O
is 16 18 6586 6588 O
unable 19 25 6589 6595 O
to 26 28 6596 6598 O
swallow 29 36 6599 6606 O
tablets 37 44 6607 6614 O
that 45 49 6615 6619 O
are 50 53 6620 6623 O
whole 54 59 6624 6629 O
( 60 61 6630 6631 O
do 61 63 6631 6633 O
not 64 67 6634 6637 O
crush 68 73 6638 6643 O
or 74 76 6644 6646 O
chew 77 81 6647 6651 O
or 82 84 6652 6654 O
administer 85 95 6655 6665 O
via 96 99 6666 6669 O
nasogastric 100 111 6670 6681 B-treatment
[ 112 113 6682 6683 I-treatment
NG]-tube 113 121 6683 6691 I-treatment
) 121 122 6691 6692 O

The 0 3 6693 6696 O
participant 4 15 6697 6708 O
requires 16 24 6709 6717 O
concomitant 25 36 6718 6729 O
treatment 37 46 6730 6739 B-treatment
with 47 51 6740 6744 O
the 52 55 6745 6748 O
following 56 65 6749 6758 O
inhibitors 66 76 6759 6769 B-treatment
of 77 79 6770 6772 I-treatment
CYP3A4 80 86 6773 6779 I-treatment

The 0 3 6780 6783 O
participant 4 15 6784 6795 O
requires 16 24 6796 6804 O
concomitant 25 36 6805 6816 B-treatment
treatment 37 46 6817 6826 I-treatment
, 46 47 6826 6827 O
in 48 50 6828 6830 O
therapeutic 51 62 6831 6842 O
doses 63 68 6843 6848 O
, 68 69 6848 6849 O
with 70 74 6850 6854 O
anticoagulants 75 89 6855 6869 B-treatment
such 90 94 6870 6874 O
as 95 97 6875 6877 O
warfarin 98 106 6878 6886 B-treatment
or 107 109 6887 6889 O
warfarin 110 118 6890 6898 B-treatment
- 118 119 6898 6899 I-treatment
related 119 126 6899 6906 I-treatment
agents 127 133 6907 6913 I-treatment
, 133 134 6913 6914 O
heparin 135 142 6915 6922 B-treatment
, 142 143 6922 6923 O
thrombin 144 152 6924 6932 B-treatment
or 153 155 6933 6935 I-treatment
factor 156 162 6936 6942 I-treatment
xabans 163 169 6943 6949 I-treatment
( 170 171 6950 6951 I-treatment
Xa 171 173 6951 6953 I-treatment
) 173 174 6953 6954 I-treatment
inhibitors 175 185 6955 6965 I-treatment
, 185 186 6965 6966 O
or 187 189 6967 6969 O
antiplatelet 190 202 6970 6982 B-treatment
agents 203 209 6983 6989 I-treatment
( 210 211 6990 6991 O
e.g. 211 215 6991 6995 O
, 215 216 6995 6996 O
clopidogrel 217 228 6997 7008 B-treatment
) 228 229 7008 7009 O
; 229 230 7009 7010 O
low 231 234 7011 7014 O
dose 235 239 7015 7019 O
aspirin 240 247 7020 7027 B-treatment
(= 248 250 7028 7030 O
< 250 251 7030 7031 O
81 252 254 7032 7034 B-upper_bound
mg 255 257 7035 7037 I-upper_bound
/ 257 258 7037 7038 O
day 258 261 7038 7041 O
) 261 262 7041 7042 O
, 262 263 7042 7043 O
low 264 267 7044 7047 O
- 267 268 7047 7048 O
dose 268 272 7048 7052 O
warfarin 273 281 7053 7061 O
(= 282 284 7062 7064 O
< 284 285 7064 7065 O
1 286 287 7066 7067 O
mg 288 290 7068 7070 O
/ 290 291 7070 7071 O
day 291 294 7071 7074 O
) 294 295 7074 7075 O
, 295 296 7075 7076 O
and 297 300 7077 7080 O
prophylactic 301 313 7081 7093 B-treatment
low 314 317 7094 7097 I-treatment
molecular 318 327 7098 7107 I-treatment
weight 328 334 7108 7114 I-treatment
heparin 335 342 7115 7122 I-treatment
( 343 344 7123 7124 I-treatment
LMWH 344 348 7124 7128 I-treatment
) 348 349 7128 7129 I-treatment
are 350 353 7130 7133 O
permitted 354 363 7134 7143 O

Thromboembolic 0 14 7144 7158 B-chronic_disease
event 15 20 7159 7164 I-chronic_disease
requiring 21 30 7165 7174 O
therapeutic 31 42 7175 7186 O
anticoagulation 43 58 7187 7202 B-treatment

Total 0 5 7203 7208 O
bilirubin= 6 16 7209 7219 B-clinical_variable
< 16 17 7219 7220 O
1.5 18 21 7221 7224 B-upper_bound
x 22 23 7225 7226 I-upper_bound
upper 24 29 7227 7232 B-clinical_variable
limit 30 35 7233 7238 I-clinical_variable
of 36 38 7239 7241 I-clinical_variable
normal 39 45 7242 7248 I-clinical_variable
( 46 47 7249 7250 I-clinical_variable
ULN 47 50 7250 7253 I-clinical_variable
) 50 51 7253 7254 I-clinical_variable
( 52 53 7255 7256 O
within 53 59 7256 7262 O
1 60 61 7263 7264 B-upper_bound
week 62 66 7265 7269 I-upper_bound
of 67 69 7270 7272 O
study 70 75 7273 7278 O
entry 76 81 7279 7284 O
) 81 82 7284 7285 O
( 83 84 7286 7287 O
if 84 86 7287 7289 O
, 86 87 7289 7290 O
however 88 95 7291 7298 O
, 95 96 7298 7299 O
the 97 100 7300 7303 O
participant 101 112 7304 7315 O
has 113 116 7316 7319 O
Gilbert 117 124 7320 7327 B-chronic_disease
's 124 126 7327 7329 I-chronic_disease
disease 127 134 7330 7337 I-chronic_disease
or 135 137 7338 7340 O
unconjugated 138 150 7341 7353 B-chronic_disease
hyperbilirubinemia 151 169 7354 7372 I-chronic_disease
that 170 174 7373 7377 O
is 175 177 7378 7380 O
considered 178 188 7381 7391 O
to 189 191 7392 7394 O
be 192 194 7395 7397 O
secondary 195 204 7398 7407 O
to 205 207 7408 7410 O
with 208 212 7411 7415 O
atazanavir 213 223 7416 7426 B-treatment
or 224 226 7427 7429 O
indinavir 227 236 7430 7439 B-treatment
therapy 237 244 7440 7447 I-treatment
, 244 245 7447 7448 O
then 246 250 7449 7453 O
the 251 254 7454 7457 O
total 255 260 7458 7463 O
bilirubin 261 270 7464 7473 O
must 271 275 7474 7478 O
be 276 278 7479 7481 O
= 279 280 7482 7483 O
< 280 281 7483 7484 O
3 282 283 7485 7486 B-upper_bound
x 284 285 7487 7488 I-upper_bound
ULN 286 289 7489 7492 O
) 289 290 7492 7493 O

Unstable 0 8 7494 7502 O
angina 9 15 7503 7509 B-chronic_disease
pectoris 16 24 7510 7518 I-chronic_disease

Urine 0 5 7519 7524 B-clinical_variable
protein 6 13 7525 7532 I-clinical_variable
/ 13 14 7532 7533 O
creatinine 14 24 7533 7543 B-clinical_variable
ratio 25 30 7544 7549 I-clinical_variable
( 31 32 7550 7551 I-clinical_variable
UPCR 32 36 7551 7555 I-clinical_variable
) 36 37 7555 7556 I-clinical_variable
= 38 39 7557 7558 O
< 39 40 7558 7559 O
1 41 42 7560 7561 B-upper_bound
( 43 44 7562 7563 O
within 44 50 7563 7569 O
1 51 52 7570 7571 B-upper_bound
week 53 57 7572 7576 I-upper_bound
of 58 60 7577 7579 O
study 61 66 7580 7585 O
entry 67 72 7586 7591 O
) 72 73 7591 7592 O

Women 0 5 7593 7598 B-gender
of 6 8 7599 7601 O
childbearing 9 21 7602 7614 O
potential 22 31 7615 7624 O
must 32 36 7625 7629 O
have 37 41 7630 7634 O
a 42 43 7635 7636 O
negative 44 52 7637 7645 B-pregnancy
pregnancy 53 62 7646 7655 I-pregnancy
test 63 67 7656 7660 O
within 68 74 7661 7667 O
7 75 76 7668 7669 B-upper_bound
days 77 81 7670 7674 I-upper_bound
before 82 88 7675 7681 I-upper_bound
enrollment 89 99 7682 7692 O

all 0 3 7693 7696 O
participants 4 16 7697 7709 O
of 17 19 7710 7712 O
reproductive 20 32 7713 7725 O
potential 33 42 7726 7735 O
must 43 47 7736 7740 O
agree 48 53 7741 7746 B-contraception_consent
to 54 56 7747 7749 I-contraception_consent
use 57 60 7750 7753 I-contraception_consent
both 61 65 7754 7758 I-contraception_consent
a 66 67 7759 7760 I-contraception_consent
barrier 68 75 7761 7768 I-contraception_consent
method 76 82 7769 7775 I-contraception_consent
and 83 86 7776 7779 O
a 87 88 7780 7781 O
second 89 95 7782 7788 B-contraception_consent
method 96 102 7789 7795 I-contraception_consent
of 103 105 7796 7798 I-contraception_consent
birth 106 111 7799 7804 I-contraception_consent
control 112 119 7805 7812 I-contraception_consent
during 120 126 7813 7819 O
the 127 130 7820 7823 O
course 131 137 7824 7830 O
of 138 140 7831 7833 O
the 141 144 7834 7837 O
study 145 150 7838 7843 O
and 151 154 7844 7847 O
for 155 158 7848 7851 O
6 159 160 7852 7853 B-upper_bound
months 161 167 7854 7860 I-upper_bound
after 168 173 7861 7866 I-upper_bound
the 174 177 7867 7870 O
last 178 182 7871 7875 O
dose 183 187 7876 7880 O
of 188 190 7881 7883 O
study 191 196 7884 7889 B-treatment
drug 197 201 7890 7894 I-treatment

alopecia 0 8 7895 7903 B-chronic_disease
and 9 12 7904 7907 O
other 13 18 7908 7913 O
non 19 22 7914 7917 O
- 22 23 7917 7918 O
clinically 23 33 7918 7928 O
significant 34 45 7929 7940 O
adverse 46 53 7941 7948 O
events 54 60 7949 7955 O
( 61 62 7956 7957 O
AEs 62 65 7957 7960 O
) 65 66 7960 7961 O

any 0 3 7962 7965 O
number 4 10 7966 7972 O
of 11 13 7973 7975 O
prior 14 19 7976 7981 B-treatment
cancer 20 26 7982 7988 I-treatment
therapies 27 36 7989 7998 I-treatment
will 37 41 7999 8003 O
be 42 44 8004 8006 O
permitted 45 54 8007 8016 O

at 0 2 8017 8019 O
least 3 8 8020 8025 O
4 9 10 8026 8027 B-lower_bound
weeks 11 16 8028 8033 I-lower_bound
must 17 21 8034 8038 O
have 22 26 8039 8043 O
elapsed 27 34 8044 8051 O
since 35 40 8052 8057 O
prior 41 46 8058 8063 B-treatment
chemotherapy 47 59 8064 8076 I-treatment
or 60 62 8077 8079 O
biological 63 73 8080 8090 B-treatment
therapy 74 81 8091 8098 I-treatment

baseline 0 8 8099 8107 O
brain 9 14 8108 8113 B-treatment
imaging 15 22 8114 8121 I-treatment
with 23 27 8122 8126 O
contrast 28 36 8127 8135 B-treatment
- 36 37 8135 8136 I-treatment
enhanced 37 45 8136 8144 I-treatment
computed 46 54 8145 8153 I-treatment
tomography 55 65 8154 8164 I-treatment
( 66 67 8165 8166 I-treatment
CT 67 69 8166 8168 I-treatment
) 69 70 8168 8169 I-treatment
or 71 73 8170 8172 O
magnetic 74 82 8173 8181 B-treatment
resonance 83 92 8182 8191 I-treatment
imaging 93 100 8192 8199 I-treatment
( 101 102 8200 8201 I-treatment
MRI 102 105 8201 8204 I-treatment
) 105 106 8204 8205 I-treatment
scans 107 112 8206 8211 I-treatment
for 113 116 8212 8215 O
participants 117 129 8216 8228 O
with 130 134 8229 8233 O
known 135 140 8234 8239 O
brain 141 146 8240 8245 B-cancer
metastases 147 157 8246 8256 I-cancer
is 158 160 8257 8259 O
required 161 169 8260 8268 O
to 170 172 8269 8271 O
confirm 173 180 8272 8279 O
eligibility 181 192 8280 8291 O

complete 0 8 8292 8300 O
wound 9 14 8301 8306 O
healing 15 22 8307 8314 O
from 23 27 8315 8319 O
prior 28 33 8320 8325 B-treatment
surgery 34 41 8326 8333 I-treatment
must 42 46 8334 8338 O
be 47 49 8339 8341 O
confirmed 50 59 8342 8351 O
at 60 62 8352 8354 O
least 63 68 8355 8360 O
28 69 71 8361 8363 B-lower_bound
days 72 76 8364 8368 I-lower_bound
before 77 83 8369 8375 O
the 84 87 8376 8379 O
first 88 93 8380 8385 O
dose 94 98 8386 8390 O
of 99 101 8391 8393 O
cabozantinib 102 114 8394 8406 B-treatment
irrespective 115 127 8407 8419 O
of 128 130 8420 8422 O
the 131 134 8423 8426 O
time 135 139 8427 8431 O
from 140 144 8432 8436 O
surgery 145 152 8437 8444 O

men 0 3 8445 8448 B-gender
treated 4 11 8449 8456 O
or 12 14 8457 8459 O
enrolled 15 23 8460 8468 O
on 24 26 8469 8471 O
this 27 31 8472 8476 O
protocol 32 40 8477 8485 O
must 41 45 8486 8490 O
also 46 50 8491 8495 O
agree 51 56 8496 8501 B-contraception_consent
to 57 59 8502 8504 I-contraception_consent
use 60 63 8505 8508 I-contraception_consent
adequate 64 72 8509 8517 I-contraception_consent
contraception 73 86 8518 8531 I-contraception_consent
prior 87 92 8532 8537 O
to 93 95 8538 8540 O
the 96 99 8541 8544 O
study 100 105 8545 8550 O
, 105 106 8550 8551 O
for 107 110 8552 8555 O
the 111 114 8556 8559 O
duration 115 123 8560 8568 O
of 124 126 8569 8571 O
study 127 132 8572 8577 O
participation 133 146 8578 8591 O
, 146 147 8591 8592 O
and 148 151 8593 8596 O
6 152 153 8597 8598 B-upper_bound
months 154 160 8599 8605 I-upper_bound
after 161 166 8606 8611 I-upper_bound
completion 167 177 8612 8622 O
of 178 180 8623 8625 O
cabozantinib 181 193 8626 8638 B-treatment
administration 194 208 8639 8653 O

participants 0 12 8654 8666 O
will 13 17 8667 8671 O
be 18 20 8672 8674 O
eligible 21 29 8675 8683 O
regardless 30 40 8684 8694 O
of 41 43 8695 8697 O
antiretroviral 44 58 8698 8712 B-treatment
medication 59 69 8713 8723 I-treatment
( 70 71 8724 8725 O
including 71 80 8725 8734 O
no 81 83 8735 8737 O
antiretroviral 84 98 8738 8752 O
medication 99 109 8753 8763 O
) 109 110 8763 8764 O
provided 111 119 8765 8773 O
there 120 125 8774 8779 O
is 126 128 8780 8782 O
no 129 131 8783 8785 O
intention 132 141 8786 8795 O
to 142 144 8796 8798 O
initiate 145 153 8799 8807 O
therapy 154 161 8808 8815 B-treatment
or 162 164 8816 8818 O
the 165 168 8819 8822 O
regimen 169 176 8823 8830 O
has 177 180 8831 8834 O
been 181 185 8835 8839 O
stable 186 192 8840 8846 O
for 193 196 8847 8850 O
at 197 199 8851 8853 O
least 200 205 8854 8859 O
4 206 207 8860 8861 B-upper_bound
weeks 208 213 8862 8867 I-upper_bound
with 214 218 8868 8872 O
no 219 221 8873 8875 O
intention 222 231 8876 8885 O
to 232 234 8886 8888 O
change 235 241 8889 8895 O
the 242 245 8896 8899 O
regimen 246 253 8900 8907 O
within 254 260 8908 8914 O
8 261 262 8915 8916 B-upper_bound
weeks 263 268 8917 8922 I-upper_bound
following 269 278 8923 8932 O
study 279 284 8933 8938 O
entry 285 290 8939 8944 O
; 290 291 8944 8945 O
as 292 294 8946 8948 O
study 295 300 8949 8954 O
- 300 301 8954 8955 O
specific 301 309 8955 8963 O
( 310 311 8964 8965 O
antiretroviral 311 325 8965 8979 O
- 325 326 8979 8980 O
based 326 331 8980 8985 O
) 331 332 8985 8986 O
strata 333 339 8987 8993 O
fill 340 344 8994 8998 O
, 344 345 8998 8999 O
however 346 353 9000 9007 O
, 353 354 9007 9008 O
only 355 359 9009 9013 O
participants 360 372 9014 9026 O
who 373 376 9027 9030 O
are 377 380 9031 9034 O
receiving 381 390 9035 9044 O
the 391 394 9045 9048 O
therapies 395 404 9049 9058 B-treatment
eligible 405 413 9059 9067 O
for 414 417 9068 9071 O
the 418 421 9072 9075 O
remaining 422 431 9076 9085 O
open 432 436 9086 9090 O
strata 437 443 9091 9097 O
will 444 448 9098 9102 O
be 449 451 9103 9105 O
accrued 452 459 9106 9113 O

participants 0 12 9114 9126 O
with 13 17 9127 9131 O
HIV 18 21 9132 9135 B-chronic_disease
infection 22 31 9136 9145 I-chronic_disease
will 32 36 9146 9150 O
be 37 39 9151 9153 O
eligible 40 48 9154 9162 O
provided 49 57 9163 9171 O
they 58 62 9172 9176 O
meet 63 67 9177 9181 O
the 68 71 9182 9185 O
criteria 72 80 9186 9194 O

participants 0 12 9195 9207 O
with 13 17 9208 9212 O
brain 18 23 9213 9218 B-cancer
metastases 24 34 9219 9229 I-cancer
previously 35 45 9230 9240 O
treated 46 53 9241 9248 O
with 54 58 9249 9253 O
whole 59 64 9254 9259 B-treatment
brain 65 70 9260 9265 I-treatment
radiation 71 80 9266 9275 I-treatment
or 81 83 9276 9278 I-treatment
radiosurgery 84 96 9279 9291 I-treatment
or 97 99 9292 9294 O
participants 100 112 9295 9307 O
with 113 117 9308 9312 O
epidural 118 126 9313 9321 B-cancer
disease 127 134 9322 9329 I-cancer
previously 135 145 9330 9340 O
treated 146 153 9341 9348 O
with 154 158 9349 9353 O
radiation 159 168 9354 9363 O
or 169 171 9364 9366 O
surgery 172 179 9367 9374 O
who 180 183 9375 9378 O
are 184 187 9379 9382 O
asymptomatic 188 200 9383 9395 O
and 201 204 9396 9399 O
do 205 207 9400 9402 O
not 208 211 9403 9406 O
require 212 219 9407 9414 O
steroid 220 227 9415 9422 B-treatment
treatment 228 237 9423 9432 I-treatment
for 238 241 9433 9436 O
at 242 244 9437 9439 O
least 245 250 9440 9445 O
4 251 252 9446 9447 B-lower_bound
weeks 253 258 9448 9453 I-lower_bound
before 259 265 9454 9460 O
starting 266 274 9461 9469 O
study 275 280 9470 9475 B-treatment
treatment 281 290 9476 9485 I-treatment
are 291 294 9486 9489 O
eligible 295 303 9490 9498 O

participants 0 12 9499 9511 O
with 13 17 9512 9516 O
known 18 23 9517 9522 O
hepatitis 24 33 9523 9532 B-chronic_disease
B 34 35 9533 9534 I-chronic_disease
infection 36 45 9535 9544 I-chronic_disease
should 46 52 9545 9551 O
be 53 55 9552 9554 O
screened 56 64 9555 9563 O
for 65 68 9564 9567 O
active 69 75 9568 9574 O
disease 76 83 9575 9582 O
prior 84 89 9583 9588 O
to 90 92 9589 9591 O
study 93 98 9592 9597 O
participation 99 112 9598 9611 O

participants 0 12 9612 9624 O
with 13 17 9625 9629 O
known 18 23 9630 9635 O
hepatitis 24 33 9636 9645 B-chronic_disease
C 34 35 9646 9647 I-chronic_disease
infection 36 45 9648 9657 O
must 46 50 9658 9662 O
not 51 54 9663 9666 O
be 55 57 9667 9669 O
actively 58 66 9670 9678 O
receiving 67 76 9679 9688 O
treatment 77 86 9689 9698 B-treatment
for 87 90 9699 9702 O
the 91 94 9703 9706 O
infectio 95 103 9707 9715 O

postmenopause 0 13 9716 9729 O
is 14 16 9730 9732 O
defined 17 24 9733 9740 O
as 25 27 9741 9743 O
amenorrhea 28 38 9744 9754 B-chronic_disease
> 39 40 9755 9756 O
= 40 41 9756 9757 O
12 42 44 9758 9760 B-lower_bound
consecutive 45 56 9761 9772 I-lower_bound
months 57 63 9773 9779 I-lower_bound

prior 0 5 9780 9785 B-treatment
radiation 6 15 9786 9795 I-treatment
therapy 16 23 9796 9803 I-treatment
to 24 26 9804 9806 O
the 27 30 9807 9810 O
thoracic 31 39 9811 9819 O
cavity 40 46 9820 9826 O
, 46 47 9826 9827 O
abdomen 48 55 9828 9835 O
, 55 56 9835 9836 O
or 57 59 9837 9839 O
pelvis 60 66 9840 9846 O
must 67 71 9847 9851 O
be 72 74 9852 9854 O
completed 75 84 9855 9864 O
at 85 87 9865 9867 O
least 88 93 9868 9873 O
3 94 95 9874 9875 B-lower_bound
months 96 102 9876 9882 I-lower_bound
prior 103 108 9883 9888 I-lower_bound
to 109 111 9889 9891 O
registration 112 124 9892 9904 O

radiotherapy 0 12 9905 9917 B-treatment
to 13 15 9918 9920 O
any 16 19 9921 9924 O
other 20 25 9925 9930 O
site 26 30 9931 9935 O
( 31 32 9936 9937 O
including 32 41 9937 9946 O
bone 42 46 9947 9951 B-cancer
or 47 49 9952 9954 O
brain 50 55 9955 9960 B-cancer
metastases 56 66 9961 9971 I-cancer
) 66 67 9971 9972 O
must 68 72 9973 9977 O
be 73 75 9978 9980 O
completed 76 85 9981 9990 O
at 86 88 9991 9993 O
least 89 94 9994 9999 O
28 95 97 10000 10002 B-lower_bound
days 98 102 10003 10007 I-lower_bound
prior 103 108 10008 10013 I-lower_bound
to 109 111 10014 10016 O
registration 112 124 10017 10029 O

sexually 0 8 10030 10038 O
active 9 15 10039 10045 O
participants 16 28 10046 10058 O
( 29 30 10059 10060 O
men 30 33 10060 10063 B-gender
and 34 37 10064 10067 I-gender
women 38 43 10068 10073 I-gender
) 43 44 10073 10074 O
must 45 49 10075 10079 O
agree 50 55 10080 10085 B-contraception_consent
to 56 58 10086 10088 I-contraception_consent
use 59 62 10089 10092 I-contraception_consent
medically 63 72 10093 10102 I-contraception_consent
accepted 73 81 10103 10111 I-contraception_consent
barrier 82 89 10112 10119 I-contraception_consent
methods 90 97 10120 10127 I-contraception_consent
of 98 100 10128 10130 I-contraception_consent
contraception 101 114 10131 10144 I-contraception_consent
( 115 116 10145 10146 O
e.g. 116 120 10146 10150 O
, 120 121 10150 10151 O
male 122 126 10152 10156 B-gender
or 127 129 10157 10159 I-gender
female 130 136 10160 10166 I-gender
condom 137 143 10167 10173 B-contraception_consent
) 143 144 10173 10174 O
during 145 151 10175 10181 O
the 152 155 10182 10185 O
course 156 162 10186 10192 O
of 163 165 10193 10195 O
the 166 169 10196 10199 O
study 170 175 10200 10205 O
and 176 179 10206 10209 O
for 180 183 10210 10213 O
6 184 185 10214 10215 B-upper_bound
months 186 192 10216 10222 I-upper_bound
after 193 198 10223 10228 O
the 199 202 10229 10232 O
last 203 207 10233 10237 O
dose 208 212 10238 10242 O
of 213 215 10243 10245 O
study 216 221 10246 10251 B-treatment
drug(s 222 228 10252 10258 I-treatment
) 228 229 10258 10259 I-treatment
, 229 230 10259 10260 O
even 231 235 10261 10265 O
if 236 238 10266 10268 O
oral 239 243 10269 10273 B-contraception_consent
contraceptives 244 258 10274 10288 I-contraception_consent
are 259 262 10289 10292 O
also 263 267 10293 10297 O
used 268 272 10298 10302 O

use 0 3 10303 10306 O
of 4 6 10307 10309 O
any 7 10 10310 10313 O
of 11 13 10314 10316 O
anti 14 18 10317 10321 B-treatment
- 18 19 10321 10322 I-treatment
retrovirals 19 30 10322 10333 I-treatment
( 31 32 10334 10335 I-treatment
delavirdine 32 43 10335 10346 I-treatment
) 43 44 10346 10347 I-treatment
or 45 47 10348 10350 O
protease 48 56 10351 10359 B-treatment
inhibitors 57 67 10360 10370 I-treatment
( 68 69 10371 10372 O
ritonavir 69 78 10372 10381 B-treatment
, 78 79 10381 10382 O
indinavir 80 89 10383 10392 B-treatment
, 89 90 10392 10393 O
lopinavir 91 100 10394 10403 B-treatment
/ 100 101 10403 10404 I-treatment
ritonavir 101 110 10404 10413 I-treatment
, 110 111 10413 10414 O
saquinavir 112 122 10415 10425 B-treatment
, 122 123 10425 10426 O
nelfinavir 124 134 10427 10437 B-treatment
) 134 135 10437 10438 O
is 136 138 10439 10441 O
permitted 139 148 10442 10451 O
; 148 149 10451 10452 O
specifically 150 162 10453 10465 O
, 162 163 10465 10466 O
ritonavir 164 173 10467 10476 O
and 174 177 10477 10480 O
cobicistat 178 188 10481 10491 B-treatment
is 189 191 10492 10494 O
permitted 192 201 10495 10504 O
for 202 205 10505 10508 O
participants 206 218 10509 10521 O
considered 219 229 10522 10532 O
for 230 233 10533 10536 O
the 234 237 10537 10540 O
CYP3A4 238 244 10541 10547 B-treatment
- 244 245 10547 10548 I-treatment
inhibitor 245 254 10548 10557 I-treatment
based 255 260 10558 10563 I-treatment
ART 261 264 10564 10567 I-treatment
regimen 265 272 10568 10575 I-treatment
arm 273 276 10576 10579 O
( 277 278 10580 10581 O
Stratum 278 285 10581 10588 O
A 286 287 10589 10590 O
) 287 288 10590 10591 O
of 289 291 10592 10594 O
the 292 295 10595 10598 O
trial 296 301 10599 10604 O
; 301 302 10604 10605 O
because 303 310 10606 10613 O
the 311 314 10614 10617 O
lists 315 320 10618 10623 O
of 321 323 10624 10626 O
CYP3A4 324 330 10627 10633 B-treatment
inhibitors 331 341 10634 10644 I-treatment
are 342 345 10645 10648 O
constantly 346 356 10649 10659 O
changing 357 365 10660 10668 O
, 365 366 10668 10669 O
it 367 369 10670 10672 O
is 370 372 10673 10675 O
important 373 382 10676 10685 O
to 383 385 10686 10688 O
regularly 386 395 10689 10698 O
consult 396 403 10699 10706 O
a 404 405 10707 10708 O
frequently 406 416 10709 10719 O
- 416 417 10719 10720 O
updated 417 424 10720 10727 O
list 425 429 10728 10732 O
; 429 430 10732 10733 O
medical 431 438 10734 10741 O
reference 439 448 10742 10751 O
texts 449 454 10752 10757 O
such 455 459 10758 10762 O
as 460 462 10763 10765 O
the 463 466 10766 10769 O
physicians 467 477 10770 10780 O
' 477 478 10780 10781 O
desk 479 483 10782 10786 O
reference 484 493 10787 10796 O
may 494 497 10797 10800 O
also 498 502 10801 10805 O
provide 503 510 10806 10813 O
this 511 515 10814 10818 O
information 516 527 10819 10830 O
; 527 528 10830 10831 O
as 529 531 10832 10834 O
part 532 536 10835 10839 O
of 537 539 10840 10842 O
the 540 543 10843 10846 O
enrollment 544 554 10847 10857 O
/ 554 555 10857 10858 O
informed 555 563 10858 10866 O
consent 564 571 10867 10874 O
procedures 572 582 10875 10885 O

women 0 5 10886 10891 B-gender
of 6 8 10892 10894 O
childbearing 9 21 10895 10907 O
potential 22 31 10908 10917 O
include 32 39 10918 10925 O
women 40 45 10926 10931 O
who 46 49 10932 10935 O
have 50 54 10936 10940 O
experienced 55 66 10941 10952 O
menarche 67 75 10953 10961 O
and 76 79 10962 10965 O
who 80 83 10966 10969 O
have 84 88 10970 10974 O
not 89 92 10975 10978 O
undergone 93 102 10979 10988 O
successful 103 113 10989 10999 O
surgical 114 122 11000 11008 B-treatment
sterilization 123 136 11009 11022 I-treatment
( 137 138 11023 11024 O
hysterectomy 138 150 11024 11036 B-treatment
, 150 151 11036 11037 O
bilateral 152 161 11038 11047 B-treatment
tubal 162 167 11048 11053 I-treatment
ligation 168 176 11054 11062 I-treatment
, 176 177 11062 11063 O
or 178 180 11064 11066 O
bilateral 181 190 11067 11076 B-treatment
oophorectomy 191 203 11077 11089 I-treatment
) 203 204 11089 11090 O
or 205 207 11091 11093 O
are 208 211 11094 11097 O
not 212 215 11098 11101 O
postmenopausal 216 230 11102 11116 O

